End-of-day quote
Korea S.E.
06:00:00 2024-06-06 pm EDT
|
5-day change
|
1st Jan Change
|
106,700
KRW
|
0.00%
|
|
+2.11%
|
-18.49%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,049,862
|
2,572,971
|
1,312,267
|
1,001,821
|
1,665,714
|
1,359,689
|
-
|
-
|
Enterprise Value (EV)
2 |
1,057
|
2,484
|
1,343
|
1,066
|
1,513
|
1,111
|
1,063
|
928.7
|
P/E ratio
|
18.6
x
|
27.6
x
|
31.8
x
|
11.5
x
|
7.97
x
|
14.9
x
|
13.3
x
|
11.2
x
|
Yield
|
0.93%
|
0.42%
|
0.9%
|
1.22%
|
0.84%
|
0.99%
|
0.96%
|
1.04%
|
Capitalization / Revenue
|
0.97
x
|
1.98
x
|
0.98
x
|
0.68
x
|
1.01
x
|
0.88
x
|
0.83
x
|
0.78
x
|
EV / Revenue
|
0.98
x
|
1.91
x
|
1.01
x
|
0.72
x
|
0.92
x
|
0.72
x
|
0.65
x
|
0.54
x
|
EV / EBITDA
|
11.2
x
|
17.1
x
|
11.3
x
|
7.72
x
|
5.48
x
|
7.44
x
|
6.4
x
|
5.05
x
|
EV / FCF
|
17.4
x
|
33.3
x
|
-40.8
x
|
55.1
x
|
5.64
x
|
8.11
x
|
8.33
x
|
5.82
x
|
FCF Yield
|
5.75%
|
3%
|
-2.45%
|
1.81%
|
17.7%
|
12.3%
|
12%
|
17.2%
|
Price to Book
|
2.11
x
|
4.46
x
|
2.24
x
|
1.54
x
|
1.96
x
|
1.54
x
|
1.4
x
|
1.26
x
|
Nbr of stocks (in thousands)
|
13,156
|
13,150
|
13,034
|
12,813
|
12,725
|
12,743
|
-
|
-
|
Reference price
3 |
79,802
|
195,659
|
100,680
|
78,190
|
130,900
|
106,700
|
106,700
|
106,700
|
Announcement Date
|
1/31/20
|
2/8/21
|
2/10/22
|
2/3/23
|
2/5/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,079
|
1,301
|
1,334
|
1,472
|
1,650
|
1,541
|
1,645
|
1,736
|
EBITDA
1 |
94.76
|
145.2
|
119.2
|
138
|
275.8
|
149.3
|
166.1
|
183.8
|
EBIT
1 |
77.02
|
126.6
|
94.09
|
107.1
|
240.8
|
115
|
131.8
|
151.1
|
Operating Margin
|
7.14%
|
9.73%
|
7.05%
|
7.27%
|
14.6%
|
7.46%
|
8.01%
|
8.7%
|
Earnings before Tax (EBT)
1 |
72.73
|
120.1
|
77.36
|
101
|
236.7
|
118.2
|
128.3
|
156.4
|
Net income
1 |
53.88
|
88.68
|
39.42
|
82.94
|
208.9
|
96.18
|
103.9
|
125
|
Net margin
|
5%
|
6.82%
|
2.95%
|
5.63%
|
12.66%
|
6.24%
|
6.32%
|
7.2%
|
EPS
2 |
4,300
|
7,082
|
3,168
|
6,771
|
16,416
|
7,156
|
8,018
|
9,491
|
Free Cash Flow
3 |
60,720
|
74,601
|
-32,942
|
19,336
|
268,167
|
137,000
|
127,512
|
159,667
|
FCF margin
|
5,629.43%
|
5,736.1%
|
-2,469.41%
|
1,313.27%
|
16,256.06%
|
8,887.74%
|
7,752.2%
|
9,198.89%
|
FCF Conversion (EBITDA)
|
64,079.32%
|
51,385.96%
|
-
|
14,007.59%
|
97,216.02%
|
91,776.92%
|
76,747.98%
|
86,885.54%
|
FCF Conversion (Net income)
|
112,690.76%
|
84,118.95%
|
-
|
23,312.61%
|
128,397.54%
|
142,441.26%
|
122,755.72%
|
127,733.33%
|
Dividend per Share
2 |
740.4
|
822.7
|
907.0
|
952.4
|
1,100
|
1,058
|
1,030
|
1,108
|
Announcement Date
|
1/31/20
|
2/8/21
|
2/10/22
|
2/3/23
|
2/5/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
355.2
|
338
|
364.8
|
380.7
|
388.9
|
360.1
|
391.8
|
396.2
|
501.5
|
353.4
|
387.8
|
396.5
|
388.3
|
390.8
|
414.6
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
123.4
|
36.01
|
42.8
|
43.95
|
28.5
|
40.1
|
46.4
|
EBIT
1 |
0.9877
|
24.33
|
28.1
|
39.66
|
15.02
|
30.06
|
43.39
|
53.07
|
114.3
|
26.75
|
32.37
|
34.27
|
21.8
|
30.95
|
38.55
|
Operating Margin
|
0.28%
|
7.2%
|
7.7%
|
10.42%
|
3.86%
|
8.35%
|
11.07%
|
13.39%
|
22.79%
|
7.57%
|
8.35%
|
8.64%
|
5.61%
|
7.92%
|
9.3%
|
Earnings before Tax (EBT)
1 |
0.353
|
23.61
|
26.04
|
37.72
|
13.58
|
30.31
|
43.26
|
52.57
|
110.6
|
31.8
|
29.27
|
33.13
|
21.2
|
28
|
39
|
Net income
1 |
-0.9111
|
17.19
|
24.48
|
29.2
|
12.07
|
34.89
|
41.83
|
43.51
|
88.63
|
25.1
|
30
|
31
|
11
|
22
|
31
|
Net margin
|
-0.26%
|
5.08%
|
6.71%
|
7.67%
|
3.1%
|
9.69%
|
10.68%
|
10.98%
|
17.67%
|
7.1%
|
7.74%
|
7.82%
|
2.83%
|
5.63%
|
7.48%
|
EPS
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/10/22
|
4/29/22
|
7/29/22
|
10/28/22
|
2/3/23
|
5/15/23
|
7/28/23
|
10/27/23
|
2/5/24
|
4/26/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
6.87
|
-
|
31.2
|
64.1
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
88.5
|
-
|
-
|
153
|
249
|
297
|
431
|
Leverage (Debt/EBITDA)
|
0.0725
x
|
-
|
0.2618
x
|
0.4646
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
2 |
60,720
|
74,601
|
-32,942
|
19,336
|
268,167
|
137,000
|
127,513
|
159,667
|
ROE (net income / shareholders' equity)
|
11.9%
|
17.4%
|
7.11%
|
14.1%
|
29.3%
|
11.2%
|
11.2%
|
12%
|
ROA (Net income/ Total Assets)
|
7.29%
|
10.4%
|
4.06%
|
7.85%
|
16.9%
|
6.88%
|
7.18%
|
7.8%
|
Assets
1 |
739.4
|
852.2
|
970.4
|
1,057
|
1,237
|
1,398
|
1,448
|
1,603
|
Book Value Per Share
3 |
37,793
|
43,836
|
44,999
|
50,699
|
66,646
|
69,217
|
76,453
|
84,460
|
Cash Flow per Share
3 |
6,452
|
8,546
|
1,228
|
5,221
|
24,287
|
10,740
|
11,436
|
13,789
|
Capex
1 |
20.1
|
32.4
|
48.2
|
44.6
|
40.8
|
38.9
|
39.4
|
39
|
Capex / Sales
|
1.87%
|
2.49%
|
3.61%
|
3.03%
|
2.48%
|
2.52%
|
2.39%
|
2.25%
|
Announcement Date
|
1/31/20
|
2/8/21
|
2/10/22
|
2/3/23
|
2/5/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW |
1st Jan change
|
Capi.
|
---|
| -18.49% | 987M | | +19.64% | 43.3B | | +21.25% | 22.22B | | +18.92% | 15.43B | | +20.14% | 14.48B | | +53.19% | 12.72B | | -0.05% | 6.79B | | -11.11% | 6.71B | | -8.87% | 5.73B | | +14.68% | 5.5B |
Generic Pharmaceuticals
|